Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine
Fig. 1 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 1

From: The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levels

Fig. 1

A 53-year-old female patient with a history of ovarian cancer who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy, and received chemotherapy. Her annual follow-up laboratory results showed elevated CA-125 levels up to 90. Initial contrast-enhanced CT (A), PET (B) and PET/CT (C) images showed no evidence of recurrence. Persistent elevated CA-125 level was reported. Follow-up CT (D), PET (E) and PET/CT (F) after 3 months showed a peritoneal nodule (arrowed) with increased FDG uptake in PET and PET/CT images (SUVmax:15) denoting recurrence with false-negative initial PET/CT study

Back to article page